Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The year 2026 may mark a turning point for availability and adoption as new oral formulations enter the U.S
Sim R, Hernndez C
The company expects to complete its Phase 3 trial program in late 2026 or early 2027, which would enable an FDA submission
That might mean feeling anxious around food, finding it hard to switch off thoughts even after regular meals, or struggling to concentrate because food keeps interrupting
US$ 20.05
US$ 25.42
US$ 20.85
US$ 27.26
US$ 24.21
US$ 26.69
US$ 26.01
US$ 29.70
US$ 20.94
